1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Baxter International Inc.

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
Jose Almeida

1 Baxter Pkwy
Deerfield, Illinois 60015-4625
Phone: 18479482000


Baxter introduces new injectable pharmaceuticals to US market
Apr 11, 2024 14:49pm
Baxter expands portfolio with new injectable products in U.S.
Apr 11, 2024 13:09pm

Baxter International expands its Pharmaceuticals portfolio in the U.S.

Source:Seeking Alpha
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
Apr 11, 2024 12:30pm

Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S. “These launches demonstrate Baxter’s focus on differentiated products that address unmet patient needs in key therapeutic areas, including anti-infective and anti-hypotensive Jetzt den vollständigen Artikel lesen

Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S. | BAX Stock News
Apr 11, 2024 12:30pm

Baxter International Inc. announces the launch of five new injectable products in the U.S., reinforcing its focus on differentiated offerings in critical therapeutic areas. The products aim to enhance patient safety and provide convenience to healthcare professionals.

Source:Stock Titan
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
Apr 10, 2024 20:15pm

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link to pre-register for the call and receive the call information. This call is also being webcast Jetzt den vollständigen Artikel lesen

EnQuest to drill biggest North Sea oil field in 20 years
Apr 10, 2024 11:57am

… Baxter, of EnQuest, said the gas initially extracted from the Bressay … see the windfall tax on oil and gas profits be increased to … having a suitable replacement to oil and gas . Labour''s Green … ;backing the UK''s oil and gas industry" and …

Source:EIN News Oil and Gas
Commercial Combi Ovens Market Size to Grow by USD 1225.74 million from 2023 to 2027, 46% of market growth is expected in Europe, Technavio
Apr 09, 2024 18:45pm

Source:Kwhen Finance
Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System
Apr 01, 2024 16:38pm

Monday, the FDA granted 510(k) clearance to Baxter International Inc’s (NYSE: BAX ) Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software . Novum IQ LVP and Novum IQ syringe infusion pump (SYR) infusion pumps share a common user interface to associate a patient, medication, and pump through a digital on-screen barcode. The pumps streamline the training clinicians need and help reduce the cognitive burden of properly operating multiple disparate pump platforms. Dose IQ Safety Software features a web-based, customizable drug library and dose error reduction system. Dose IQ supports clinicians and hospitals by helping ensure … Full story available on

‘It’s madness’: Exeter’s Baxter attacks World Rugby’s latest law change plans
Apr 01, 2024 16:00pm

Global governing body wants to tweak maul and scrum laws ‘The best way to create space is to power up the maul’ World Rugby’s latest flurry of law change recommendations have been criticised as “madness” by a leading English Premiership director of rugby. Rob Baxter of Exeter Chiefs argues that constant tinkering with the game’s laws and interpretations is confusing new spectators and is undermining the sport’s ambitions for global growth. Just over a fortnight ago, World Rugby announced a raft of proposed measures aimed at broadening the appeal of the sport by, among other things, reducing the number of times a rolling maul can be restarted and looking to encourage fewer scrum resets. Few of the initiatives have impressed Baxter, a strong believer that rugby has an unhealthy obsession with tweaking laws. Continue reading…

Source:The Guardian
Baxter gains FDA clearance for new infusion pump system
Apr 01, 2024 11:27am